IL142220A0 - Method of treating viral hemorrhagic fever - Google Patents

Method of treating viral hemorrhagic fever

Info

Publication number
IL142220A0
IL142220A0 IL14222099A IL14222099A IL142220A0 IL 142220 A0 IL142220 A0 IL 142220A0 IL 14222099 A IL14222099 A IL 14222099A IL 14222099 A IL14222099 A IL 14222099A IL 142220 A0 IL142220 A0 IL 142220A0
Authority
IL
Israel
Prior art keywords
hemorrhagic fever
viral hemorrhagic
treating viral
provides
toxicity
Prior art date
Application number
IL14222099A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL142220A0 publication Critical patent/IL142220A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14222099A 1998-11-20 1999-11-15 Method of treating viral hemorrhagic fever IL142220A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10915398P 1998-11-20 1998-11-20
PCT/US1999/027074 WO2000030677A1 (en) 1998-11-20 1999-11-15 Method of treating viral hemorrhagic fever

Publications (1)

Publication Number Publication Date
IL142220A0 true IL142220A0 (en) 2002-03-10

Family

ID=22326085

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14222099A IL142220A0 (en) 1998-11-20 1999-11-15 Method of treating viral hemorrhagic fever

Country Status (12)

Country Link
US (2) US6270764B1 (ja)
EP (1) EP1131091B1 (ja)
JP (1) JP2002530353A (ja)
CN (1) CN1326356A (ja)
AT (1) ATE235915T1 (ja)
AU (1) AU2149800A (ja)
BR (1) BR9915460A (ja)
CA (1) CA2351470A1 (ja)
DE (1) DE69906568T2 (ja)
ES (1) ES2195655T3 (ja)
IL (1) IL142220A0 (ja)
WO (1) WO2000030677A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69906568T2 (de) * 1998-11-20 2004-02-12 Eli Lilly And Co., Indianapolis Behandlung von hämorrhagischem virusfieber mit protein c
WO2002024215A2 (en) * 2000-09-18 2002-03-28 Eli Lilly And Company Method for using activated protein c for the treatment of coagulation-associated disorders
KR20040040489A (ko) 2001-10-15 2004-05-12 카이론 코포레이션 조직 인자 경로 억제제（ｔｆｐｉ）의 저용량 투여에 의한패혈증의 치료
US7132398B2 (en) 2003-05-06 2006-11-07 Dendreon Corporation Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor
SG150552A1 (en) * 2004-03-17 2009-03-30 Chiron Corp Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi)
WO2007092607A2 (en) * 2006-02-09 2007-08-16 Genetech, Inc. Treatment of hemorrhagic viral infections using a tissue factor inhibitor
AU2016431615A1 (en) * 2016-12-08 2019-06-20 Cellphire, Inc. Compositions and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
US20200224164A1 (en) 2018-11-30 2020-07-16 Cellphire, Inc. Platelets as delivery agents
EP3886879A4 (en) 2018-11-30 2022-12-07 Cellphire Inc. PLATES AS DELIVERY AGENTS
WO2020227149A1 (en) 2019-05-03 2020-11-12 Cellphire, Inc. Materials and methods for producing blood products
EP4013496A4 (en) 2019-08-16 2023-10-18 Cellphire Inc. THROMBOSOMES AS AN ANTI-PLATELET DEACTIVATING AGENT
WO2021158622A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Anti-fibrinolytic loaded platelets

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
US5516650A (en) 1985-06-27 1996-05-14 Zymogenetics, Inc. Production of activated protein C
US5550036A (en) 1986-04-09 1996-08-27 Eli Lilly And Company Method for co-amplification of human protein C genes in human cells
US4992373A (en) 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
US4981952A (en) 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
IL97312A (en) 1990-02-23 1999-01-26 Lilly Co Eli A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient
US5506134A (en) * 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
AT402262B (de) 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
MY110664A (en) 1992-05-21 1999-01-30 Lilly Co Eli Protein c derivatives
WO1997020043A1 (en) 1995-11-30 1997-06-05 Zymogenetics, Inc. Protein c production in transgenic animals
EA002149B1 (ru) * 1997-04-28 2001-12-24 Эли Лилли Энд Компани Улучшенные способы приготовления активированного белка с
DE69906568T2 (de) * 1998-11-20 2004-02-12 Eli Lilly And Co., Indianapolis Behandlung von hämorrhagischem virusfieber mit protein c
AU4188500A (en) * 1999-04-30 2000-11-17 Eli Lilly And Company Protein c derivatives

Also Published As

Publication number Publication date
EP1131091A1 (en) 2001-09-12
AU2149800A (en) 2000-06-13
US20010028880A1 (en) 2001-10-11
CN1326356A (zh) 2001-12-12
WO2000030677A1 (en) 2000-06-02
JP2002530353A (ja) 2002-09-17
EP1131091B1 (en) 2003-04-02
BR9915460A (pt) 2001-07-17
DE69906568T2 (de) 2004-02-12
ATE235915T1 (de) 2003-04-15
DE69906568D1 (de) 2003-05-08
CA2351470A1 (en) 2000-06-02
US6270764B1 (en) 2001-08-07
US6767539B2 (en) 2004-07-27
ES2195655T3 (es) 2003-12-01

Similar Documents

Publication Publication Date Title
BG103671A (en) Combinations of sulphonylcarbamide-glytazone having synergetic effect for the treatment of diabetes
ATE234092T1 (de) 2-alkylpyrrolidine
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
TR199900083T2 (xx) Klaritromisinin kristal bi�imi I.
PT2329829E (pt) Utilização de uridina em combinação com colina para o tratamento de disfunções neurológicas
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
IL142220A0 (en) Method of treating viral hemorrhagic fever
BG100930A (en) Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
WO2000021513A3 (en) Methods for treating multiple sclerosis
EP1632248B8 (en) Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness
MX9605072A (es) Dispositivo dispensador para pretratamiento.
EP0318233A3 (en) Improvements in or relating to serotonin and norepinephrine uptake inhibitors
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
IL142255A0 (en) Method of treating heparin-induced thrombocytopenia
HU9700024D0 (en) Imidazopyridin-azolidinones
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
IL142247A0 (en) Method of treating sickle cell disease and thalassemia
IL142249A0 (en) Method of treating thrombocytopenic purpura and hemolytic uremic syndrome
EP0116628A4 (en) 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS AN ANI-HYPERTENSIVE.
EP1083914A4 (en) TREATING ARTHRITIS AND OTHER SIMILAR DISORDERS
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
IL138117A0 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь